Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Abraham Ceesay currently holds 452,245 shares of Cerevel Therapeutics Holdings, Inc. (CERE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Abraham Ceesay has been a net seller of CERE stock. They have purchased $0 and sold $6.4M worth of shares.
Abraham Ceesay's most recent insider trade was on Oct 7, 2026, when they sold 1,147 shares at $30.66 per share.
Abraham Ceesay serves as Executive at Cerevel Therapeutics Holdings, Inc. (CERE). They have executed 36 insider transactions totaling $6.4M over their tenure at the company.
Abraham Ceesay holds the position of Executive at Cerevel Therapeutics Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Abraham Ceesay has shown a selling trading pattern, with $0 in total purchases and $6.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Abraham Ceesay was on Aug 5, 2022, when they sold $1.2M worth of CERE shares. This transaction involved 38,424 shares at $32.50 per share.
Abraham Ceesay currently owns 452,245 shares of Cerevel Therapeutics Holdings, Inc. (CERE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Abraham Ceesay's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Abraham Ceesay has 36 Form 4 filings on record as an insider at Cerevel Therapeutics Holdings, Inc..
Set alerts for Abraham Ceesay and 40,000+ other insiders.